ABT
Price
$119.51
Change
+$0.90 (+0.76%)
Updated
Mar 4, 11:59 AM EST
44 days until earnings call
SYK
Price
$353.21
Change
+$4.26 (+1.22%)
Updated
Mar 1, 6:59 PM EST
50 days until earnings call
Ad is loading...

Analysis and predictions ABT vs SYK

Header iconABT vs SYK Comparison
Open Charts ABT vs SYKBanner chart's image
Abbott Laboratories
Price$119.51
Change+$0.90 (+0.76%)
Volume$2.97K
CapitalizationN/A
Stryker
Price$353.21
Change+$4.26 (+1.22%)
Volume$223.09K
CapitalizationN/A
View a ticker or compare two or three
ABT vs SYK Comparison Chart

Loading...

ABTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SYKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ABT vs. SYK commentary
Mar 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and SYK is a Hold.

COMPARISON
Comparison
Mar 04, 2024
Stock price -- (ABT: $118.62 vs. SYK: $353.22)
Brand notoriety: ABT: Notable vs. SYK: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 76% vs. SYK: 96%
Market capitalization -- ABT: $205.83B vs. SYK: $134.32B
ABT [@Medical Specialties] is valued at $205.83B. SYK’s [@Medical Specialties] market capitalization is $134.32B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 3 FA rating(s) are green whileSYK’s FA Score has 3 green FA rating(s).

  • ABT’s FA Score: 3 green, 2 red.
  • SYK’s FA Score: 3 green, 2 red.
According to our system of comparison, SYK is a better buy in the long-term than ABT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 3 bullish TA indicator(s).

  • ABT’s TA Score: 4 bullish, 4 bearish.
  • SYK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABT is a better buy in the short-term than SYK.

Price Growth

ABT (@Medical Specialties) experienced а -0.70% price change this week, while SYK (@Medical Specialties) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.62%. For the same industry, the average monthly price growth was +3.86%, and the average quarterly price growth was +2.32%.

Reported Earning Dates

ABT is expected to report earnings on Apr 17, 2024.

SYK is expected to report earnings on Apr 23, 2024.

Industries' Descriptions

@Medical Specialties (+2.62% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ABT with price predictions.
OPEN
A.I.dvisor published
a Summary for SYK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ABT($206B) has a higher market cap than SYK($134B). SYK has higher P/E ratio than ABT: SYK (42.81) vs ABT (36.39). SYK YTD gains are higher at: 17.952 vs. ABT (8.288). ABT has higher annual earnings (EBITDA): 10.5B vs. SYK (4.93B). ABT has more cash in the bank: 7.28B vs. SYK (3.05B). SYK has less debt than ABT: SYK (13B) vs ABT (15.6B). ABT has higher revenues than SYK: ABT (40.1B) vs SYK (20.5B).
ABTSYKABT / SYK
Capitalization206B134B154%
EBITDA10.5B4.93B213%
Gain YTD8.28817.95246%
P/E Ratio36.3942.8185%
Revenue40.1B20.5B196%
Total Cash7.28B3.05B238%
Total Debt15.6B13B120%
FUNDAMENTALS RATINGS
ABT vs SYK: Fundamental Ratings
ABT
SYK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
2512
SMR RATING
1..100
5952
PRICE GROWTH RATING
1..100
2717
P/E GROWTH RATING
1..100
2657
SEASONALITY SCORE
1..100
55n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (19) in the Medical Specialties industry is significantly better than the same rating for ABT (90). This means that SYK’s stock grew significantly faster than ABT’s over the last 12 months.

SYK's Profit vs Risk Rating (12) in the Medical Specialties industry is in the same range as ABT (25). This means that SYK’s stock grew similarly to ABT’s over the last 12 months.

SYK's SMR Rating (52) in the Medical Specialties industry is in the same range as ABT (59). This means that SYK’s stock grew similarly to ABT’s over the last 12 months.

SYK's Price Growth Rating (17) in the Medical Specialties industry is in the same range as ABT (27). This means that SYK’s stock grew similarly to ABT’s over the last 12 months.

ABT's P/E Growth Rating (26) in the Medical Specialties industry is in the same range as SYK (57). This means that ABT’s stock grew similarly to SYK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTSYK
RSI
ODDS (%)
Bearish Trend 4 days ago
39%
Bearish Trend 4 days ago
61%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
48%
Bearish Trend 4 days ago
52%
Momentum
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
60%
MACD
ODDS (%)
Bullish Trend 4 days ago
62%
Bearish Trend 4 days ago
39%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
56%
Bullish Trend 4 days ago
61%
Advances
ODDS (%)
Bullish Trend 6 days ago
56%
Bullish Trend 11 days ago
57%
Declines
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 5 days ago
48%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
50%
Bearish Trend 4 days ago
42%
Aroon
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
60%
View a ticker or compare two or three
Ad is loading...
ABTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SYKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBRX0.720.04
+5.98%
Forte Biosciences
CDE2.710.12
+4.63%
Coeur Mining
HBB18.050.52
+2.97%
Hamilton Beach Brands Holding Company
EPRT24.370.48
+2.01%
Essential Properties Realty Trust
SYY79.96-1.01
-1.25%
Sysco Corp

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been closely correlated with IDXX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ABT jumps, then IDXX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-0.02%
IDXX - ABT
66%
Closely correlated
+0.29%
MDT - ABT
63%
Loosely correlated
+0.29%
RVTY - ABT
60%
Loosely correlated
-2.25%
BAX - ABT
55%
Loosely correlated
+0.22%
ISRG - ABT
52%
Loosely correlated
+3.19%
More

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been closely correlated with BSX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
+1.19%
BSX - SYK
68%
Closely correlated
+1.39%
ZBH - SYK
61%
Loosely correlated
-0.28%
RVTY - SYK
60%
Loosely correlated
-2.25%
ISRG - SYK
59%
Loosely correlated
+3.19%
ABT - SYK
52%
Loosely correlated
-0.02%
More